Chronic Hepatitis C
HEPATITIS C --- Navigation Topics
• Top New Articles on HCV
• All HCV Articles by Topic ( A to Z )
• HCV Basics
• HIV-HCV Coinfection
• FDA-approved Treatments for HCV
- Roferon A (interferon alfa-2a)
- Intron A (interferon alfa-2b)
- Infergen (consensus interferon)
- Pegasys (peginterferon alfa-2a)
- PegIntron (peginterferon alfa-2b)
- Copegus / Rebetol (ribavirin)
- Intron A + Rebetol
- Roferon A + Ribavirin
- Pegasys + Copegus
- PegIntron + Rebetol
• Treatment Guidelines for HCV
• Experimental Treatments for HCV
• Recent Research Conference Reports
• Tests for HCV
• Liver-related Complications
• Drug-related Adverse Events
• Doctor Is In 'Q and A' for HCV
• Library of CME Programs
• E-mail Update - Sign Up
• About Us - Contact Us
_______________
Weight-based Dosing of
PEG-Intron Plus Ribavirin
Differences in Outcomes of Treatment with PegIntron Plus Fixed-dose or
Weight-based Ribavirin
Based on Genotype and Viral Load in HCV Genotypes 2 and 3 in The WIN-R Trial
- 5/23/06
Peginterferon Alfa-2b (PegIntron) as Maintenance Monotherapy for HIV-HCV Coinfected Patients: The ENDURE Study
- 1/17/06
Does
Weight-based Ribavirin Dosing
Increase Sustained Viral Response in Patients with Chronic Hepatitis C? Final Results of the WIN-R Study
- 11/18/05
Weight Loss
during Pegylated Interferon and Ribavirin Treatment of Chronic Hepatitis C
- 10/14/05
Predictors of Treatment Failure in Patients with Hepatitis C Genotypes 2 or 3
- 6/01/05
The Effect of
Weigh
t on Exposure in Hepatitis C: Peginterferon Alfa-2b (PegIntron) and Peginterferon Alfa-2a (Pegasys)
- 5/18/05
Double-dose Peginterferon Alfa-2b Plus
Weight-based
Ribavirin for Retreatment of African-American Non-Responders with Hepatitis C
- 5/18/05
Area-under-the-curve for Peginterferon Alfa-2a (Pegasys) and Peginterferon Alfa-2b (PegIntron) Is Not Related to Body Weight in Treatment-naive Patients with Chronic Hepatitis C
- 5/09/05
HIV AND AIDS
|
HEPATITIS B
|
HEPATITIS C
|
HIV / HBV CO-INFECTION
|
HIV / HCV CO-INFECTION
|
HEALTH AND TECHNOLOGY
|
TESTS
|
INTERNET CONFERENCE REPORTS
|
TELECONFERENCES
|
LINKS
|
ABOUT US
|
CONTACT US
